These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 16307387

  • 1. A clinical and molecular overview of the human osteopetroses.
    Balemans W, Van Wesenbeeck L, Van Hul W.
    Calcif Tissue Int; 2005 Nov; 77(5):263-74. PubMed ID: 16307387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Osteoclast biology: lessons from mammalian mutations.
    Marks SC.
    Am J Med Genet; 1989 Sep; 34(1):43-54. PubMed ID: 2683780
    [Abstract] [Full Text] [Related]

  • 5. Human osteopetroses and the osteoclast V-H+-ATPase enzyme system.
    Ogbureke KU, Zhao Q, Li YP.
    Front Biosci; 2005 Sep 01; 10():2940-54. PubMed ID: 15970548
    [Abstract] [Full Text] [Related]

  • 6. Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology.
    Van Wesenbeeck L, Van Hul W.
    Crit Rev Eukaryot Gene Expr; 2005 Sep 01; 15(2):133-62. PubMed ID: 16022633
    [Abstract] [Full Text] [Related]

  • 7. Sclerosing bone disorders.
    de Vernejoul MC.
    Best Pract Res Clin Rheumatol; 2008 Mar 01; 22(1):71-83. PubMed ID: 18328982
    [Abstract] [Full Text] [Related]

  • 8. Osteopetroses, emphasizing potential approaches to treatment.
    Teti A, Econs MJ.
    Bone; 2017 Sep 01; 102():50-59. PubMed ID: 28167345
    [Abstract] [Full Text] [Related]

  • 9. Heritable sclerosing bone disorders: presentation and new molecular mechanisms.
    de Vernejoul MC, Kornak U.
    Ann N Y Acad Sci; 2010 Mar 01; 1192():269-77. PubMed ID: 20392246
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Recessive osteopetrosis. Identification of a form of medium severity].
    Bejaoui M, Baraket M, Lakhoua R, Mezni F, Hammou Jeddi A, Kamoun A, Kharrat H, Essoussi S, Harbi A, Ben Dridi MF.
    Arch Fr Pediatr; 1992 Mar 01; 49(7):627-31. PubMed ID: 1476480
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of bone loss.
    Murray TM.
    J Rheumatol Suppl; 1996 Aug 01; 45():6-10. PubMed ID: 8856644
    [Abstract] [Full Text] [Related]

  • 14. Experimental studies of osteopetrosis in laboratory animals.
    Seifert MF, Popoff SN, Jackson ME, MacKay CA, Cielinski M, Marks SC.
    Clin Orthop Relat Res; 1993 Sep 01; (294):23-33. PubMed ID: 8358920
    [Abstract] [Full Text] [Related]

  • 15. Osteopetroses and immunodeficiencies in humans.
    Villa A, Vezzoni P, Frattini A.
    Curr Opin Allergy Clin Immunol; 2006 Dec 01; 6(6):421-7. PubMed ID: 17088646
    [Abstract] [Full Text] [Related]

  • 16. Congenital osteopetrotic mutations as probes of the origin, structure, and function of osteoclasts.
    Marks SC.
    Clin Orthop Relat Res; 1984 Oct 01; (189):239-63. PubMed ID: 6434217
    [Abstract] [Full Text] [Related]

  • 17. Towards a better understanding and new therapeutics of osteopetrosis.
    Askmyr MK, Fasth A, Richter J.
    Br J Haematol; 2008 Mar 01; 140(6):597-609. PubMed ID: 18241253
    [Abstract] [Full Text] [Related]

  • 18. The osteoclast and osteoporosis.
    Teitelbaum SI.
    Mt Sinai J Med; 1996 Mar 01; 63(5-6):399-402. PubMed ID: 8898546
    [No Abstract] [Full Text] [Related]

  • 19. The osteoclast-not always guilty.
    Mundy GR, Edwards JR.
    Cell Metab; 2007 Sep 01; 6(3):157-9. PubMed ID: 17767902
    [Abstract] [Full Text] [Related]

  • 20. The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment.
    Schaller S, Henriksen K, Sørensen MG, Karsdal MA.
    Drug News Perspect; 2005 Oct 01; 18(8):489-95. PubMed ID: 16391718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.